89bio, Inc.

89bio, Inc.

ETNB

$14.84

Updated: 22/09/2026, 09:32:31

Market Cap
$2.20B
Sector
Healthcare
Industry
Biotechnology
Country
US
Stock valuation chart
One-year closing share-price history for ETNB
Company Profile

Operating as a clinical-stage biopharmaceutical company, 89bio, Inc. is dedicated to advancing and commercializing therapeutic solutions for ailments impacting the liver and metabolic system. Their flagship product candidate, pegozafermin, is a modified fibroblast growth factor 21 (FGF21) analog specifically designed to address nonalcoholic steatohepatitis (NASH). Furthermore, the company has plans to explore pegozafermin's utility in treating severe hypertriglyceridemia. Founded in 2018, 89bio, Inc. maintains its corporate headquarters in San Francisco, California.

USD
NASDAQ
CEO: Rohan Palekar
Employees: 93
https://www.89bio.com
Asset Summaries
Latest generated summaries for ETNB

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for ETNB.
Share price
$14.84
Market cap
$2.20B
Exchange
NASDAQ
Currency
USD
CEO
Rohan Palekar
Employees
93
IPO date
11/11/2019
Beta
1.263
Last dividend
$0.00
Day range
$14.84 – $14.84
52-week range
$4.16 – $15.06
1-day performance
0.00%
1-year performance
256.73%
Current drawdown (1Y)
-1.46%
CIK
0001785173
CUSIP
282559103
ISIN
US2825591033
Created
07/12/2025, 03:51:13
Last update
22/09/2026, 09:32:31

Track 89bio, Inc. with an AI analyst

See which prediction-market events move ETNB, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to ETNB from your Railway `news_articles` table.

No news found for this symbol.